about
Vaccines against tuberculosis: where are we and where do we need to go?Simultaneous immunization against tuberculosisScreening for potential adjuvants administered by the pulmonary route for tuberculosis vaccines.Preparation and characterization of beta-glucan particles containing a payload of nanoembedded rifabutin for enhanced targeted delivery to macrophages.Application of nanotechnologies for improved immune response against infectious diseases in the developing worldAerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.Pulmonary immunization of guinea pigs with diphtheria CRM-197 antigen as nanoparticle aggregate dry powders enhance local and systemic immune responses.The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update.Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in miceExtended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidate.Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques.Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosisThe TB-specific CD4(+) T cell immune repertoire in both cynomolgus and rhesus macaques largely overlap with humans.Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human PapillomavirusLessons for tuberculosis vaccines from respiratory virus infection.Fighting tuberculosis: old drugs, new formulations.Tuberculosis vaccines: present and future.Pharmaceutical aerosols for the treatment and prevention of tuberculosisNanocarriers targeting dendritic cells for pulmonary vaccine delivery.Devices and formulations for pulmonary vaccination.Aerosol immunisation for TB: matching route of vaccination to route of infectionNasal and pulmonary vaccine delivery using particulate carriers.Mycobacteria Manipulate G-Protein-Coupled Receptors to Increase Mucosal Rac1 Expression in the Lungs.Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination.Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.Formulation and stabilization of Francisella tularensis live vaccine strain.Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection.Non-pathological infection of macaques by an attenuated mycobacterial vaccine is not reactivated in the setting of HIV coinfection.Immunization of guinea pigs with novel hepatitis B antigen as nanoparticle aggregate powders administered by the pulmonary routeDevelopments in the formulation and delivery of spray dried vaccines.Intranasal immunization with dry powder vaccines.The α4β1 integrin in localization of Mycobacterium tuberculosis-specific T helper type 1 cells to the human lung.Recent developments in tuberculosis vaccinesSpray Drying Strategies to Stop Tuberculosis
P2860
Q26992233-0E34ACBD-ED7F-4B3A-BAFA-ED9114831668Q28742666-13337884-8905-49D8-BDF5-A22E03404196Q33416980-A0A11CA1-39B3-439C-AB03-6DADF35ED7BDQ33667215-7250A68A-A9F3-408B-9AAA-3FA2100353FDQ33894321-511334D5-EFAA-4A15-8BA9-6BF59C9867AAQ33992101-A451ED74-0214-4E4E-91E4-0117835E5913Q34293599-F9CD36A8-7CF4-4E26-8E5E-DD72F5B1952CQ34433909-8573B6AE-2A0E-4F2E-A2EF-C06BE2646311Q34722855-7A18C8EC-1A12-459B-A787-22F0F1773B3EQ35135987-0A793406-D663-4ED1-A64D-B01912F2954BQ35998753-395D0EA8-1AD0-4F2E-8E41-C315DB26372CQ36169358-7147EB59-0658-4FFB-8328-723C70FBBFDCQ36636763-D8EED985-20EE-4BBC-B3AC-C80A4BA0FF29Q36858686-1F25C941-A0EB-4C87-AB37-E1B71768EB6BQ37290093-188C4578-EC7A-4711-B3EB-2C4AEF2D2DF8Q37579212-6777F234-B6D9-4ADC-9ED3-6BFE48FB1867Q37754908-2A214CDB-3E61-47FB-8BD7-0FBD0099E9FDQ38042953-484C1EA1-BDCB-4A07-BF5E-E72B0884BFE2Q38051096-4BD8D6A4-76C2-4156-A61A-B6E103E83524Q38115814-2ACA9D74-865F-439D-BB96-19EA3DF764D9Q38338183-A65981A6-9550-453D-A6DF-98C47D9169F1Q38465267-8D465AFA-6B20-4F86-8727-3FAFDD718A61Q38778343-EFB24A3F-98EB-490F-B8DE-6601DB683448Q38818697-7892F226-97BE-4D67-924D-EC0ADB929A2AQ39390000-7D0C34FA-37C0-48FC-8323-B6165968530FQ39558903-FB89E028-A26D-42E0-BB21-984439CAE100Q41645299-26EF93D8-DD05-4C8D-8590-A3155BEA6D7EQ41932554-B2F39706-69F1-4B7D-8DAD-7F95CB63D443Q41950285-718A53D3-53D1-4C2D-8184-242DD9CFBF86Q47106090-AA637EA5-303F-4E1D-9855-8CEB480A3AC0Q47584590-7367FB46-7A4F-4203-A2E7-0041ACB8838DQ48344195-47FFDDB3-D1E4-4087-BC59-3435B25E9558Q58834925-8BF8A392-D945-43D1-A352-93575929DBB8Q59291746-F3A06BD4-8D30-4BA2-A05C-F00E0D8D2B17
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Immunization by a bacterial aerosol
@ast
Immunization by a bacterial aerosol
@en
type
label
Immunization by a bacterial aerosol
@ast
Immunization by a bacterial aerosol
@en
prefLabel
Immunization by a bacterial aerosol
@ast
Immunization by a bacterial aerosol
@en
P2093
P2860
P356
P1476
Immunization by a bacterial aerosol
@en
P2093
Anthony Hickey
Barry R Bloom
Danielle Padilla
David Edwards
Jerry Sadoff
Jessica Derousse
Katharina Elbert
Lucila Garcia-Contreras
P Bernard Fourie
Pavan Muttil
P2860
P304
P356
10.1073/PNAS.0800043105
P407
P577
2008-03-14T00:00:00Z